ENTITY
Shenzhen Hepalink Pharma

Shenzhen Hepalink Pharma (002399 CH)

49
Analysis
Health CareChina
Shenzhen Hepalink Pharmaceutical Co., Ltd researches, produces and sells heparin pharmaceuticals products. The Company's products include heparin sodium active pharmaceutical ingredient.
more
Refresh
05 Nov 2023 10:10

A-H Premium Weekly (Nov 3rd): Ganfeng Lithium, CMS, Wuxi Apptec

We analyzed A-H premium changes in the past week and highlight A-H premium changes for Ganfeng Lithium, China Merchant Securities and Wuapptec.

Logo
445 Views
Share
08 Oct 2023 10:15

A-H Premium Weekly (Oct 6th): CMB, Postal Savings, Conch Cement, Beigene, Sinopec

We analyzed A-H premium changes in the past week and highlight A-H premium changes for Cm Bank, Postal Savings, Conch Cement, Beigene, Sinopec Corp.

Logo
412 Views
Share
11 Sep 2023 07:00

CSI500 Index Rebalance Preview: ETF Inflows Lead to Performance Skew

There should be 50 changes in Dec with a big sector skew. Turnover is ~10% and 31 stocks will have 1x ADV to trade. Huge ETF inflows have led to...

Logo
575 Views
Share
07 May 2023 10:15

A-H Premium Weekly (May 5th): CCB, BOC, Sinopec, China Shenhua, CMOC, CRRC, China Southern Airlines

We analyzed A-H premium changes in the past week and highlight A-H premium changes for CCB, BOC, Sinopec, China Shenhua, CMOC, CRRC, China Southern...

Logo
267 Views
Share
01 May 2023 13:12

A-H Premium Weekly (Apr 28th): Sinopec, China Shenhua, CRRC, Tigermed, GWM

We analyzed A-H premium changes in the past week and highlight A-H premium changes for Postal Savings, BankComm, CCB, Sinopec, China Shenhua, CRRC,...

Logo
276 Views
Share
x